Working… Menu

Use of In-Line Filtration in Critically Ill Children

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00209768
Recruitment Status : Completed
First Posted : September 21, 2005
Last Update Posted : December 1, 2008
Pall Corporation
B. Braun Melsungen AG
Information provided by:
Hannover Medical School

Brief Summary:
The purpose of this study is to determine whether the use of in-line filtration shows any effect on the outcome of sepsis, systemic inflammatory response syndrome (SIRS), thrombosis, or organ failure in critically ill children admitted to the pediatric intensive care unit (PICU).

Condition or disease Intervention/treatment Phase
Critical Illness Device: Filter: NOE96E, ELD96E, NLF1E, TNA1E Phase 4

Detailed Description:

Scientific background:

Particulate contamination of infusion solutions and their systemic administration during infusion therapy has been linked to various clinical problems.

Organ failure and Multi-Organ Failure (MOV):

It is well established that the pathophysiology of MOV involves deteriorations of the microcirculation and integrity of endothelial cells. As a consequence of this an imbalance between pro- and anticoagulatory factors may develop and microthrombi may form. Mediators like tissue factor (TF) and platelet activating factor (PAF) have been linked to the formation of microthrombi.

Particles have been discussed as a causative agent for this syndrome by various authors. Their effect on morbidity and mortality of patients has however not yet been established.

Particles may have additional harmful effects:

  • Direct thrombogenesis by the particle material
  • Damaging endothelial cells in the capillary network
  • Embolisation of the pulmonary vasculature
  • Acting as a cristallisation focus for the development of granuloma
  • Promoting the formation of Giant Cells

Various authors have shown that the use of end line infusion filters significantly reduces the rate of thrombophlebitis. A recently published study by van Lingen et al. (2004) also showed that the use of end line infusion filters significantly reduced the rate of overall complications in neonates.

Study Hypothesis:

The use of end line positively charged 0.2 µm and uncharged 1.2 µm infusion filters will prevent particles, microorganisms and their endotoxins from the infusate to enter the patient's circulation in the study group and will reduce significantly the complication rate of these patients.

The following clinical diagnoses are defined as "Complications". They are main contributors to morbidity and mortality in intensive care wards:

  • catheter related thrombosis of the central veins
  • sepsis with proven infectious organisms
  • Septic syndrome without proven infectious organisms
  • Failure of one of the following organs/systems

    1. Lung
    2. Kidney
    3. Liver
    4. Circulation

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 821 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Randomised, Prospective Study of the Use of In-Line Filtration on the Reduction of Complication Rate in Critically Ill Children
Study Start Date : February 2005
Actual Primary Completion Date : September 2008
Actual Study Completion Date : September 2008

Primary Outcome Measures :
  1. Sepsis
  2. Thrombosis
  3. SIRS
  4. Organ failure
  5. Composite primary outcome including "sepsis, SIRS, thrombosis, organ failure"

Secondary Outcome Measures :
  1. Duration of Pediatric Intensive Care Unit stay
  2. Duration of overall hospital stay

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Children admitted to pediatric intensive care unit (PICU)

Exclusion Criteria:

  • Suspected death within 48 hours
  • Duration of PICU stay less than 6 hours
  • Patients recruited for Simulect or Sintra Study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00209768

Layout table for location information
Hannover Medical School
Hannover, Niedersachsen, Germany, 30625
Sponsors and Collaborators
Hannover Medical School
Pall Corporation
B. Braun Melsungen AG
Layout table for investigator information
Study Director: Michael Sasse, Consultant Medical School Hannover
Principal Investigator: Thomas Jack, Doctor Medical School Hannover
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information Identifier: NCT00209768    
Other Study ID Numbers: 3702
First Posted: September 21, 2005    Key Record Dates
Last Update Posted: December 1, 2008
Last Verified: September 2008
Keywords provided by Hannover Medical School:
pediatric intensive care
critically ill children
in-line filtration
prospective randomized study
organ failure
Additional relevant MeSH terms:
Layout table for MeSH terms
Critical Illness
Disease Attributes
Pathologic Processes